Accessibility Menu
Organigram Global Stock Quote

Organigram Global (NASDAQ: OGI)

$1.31
(-5.8%)
-0.08
Price as of February 11, 2026, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$1.31
Daily Change
(-5.8%) $0.08
Day's Range
$1.29 - $1.42
Previous Close
$1.31
Open
$1.41
Beta
1.54
Volume
1,672,459
Average Volume
1,108,753
Market Cap
$177M
Market Cap / Employee
$1.31M
52wk Range
$0.85 - $2.24
Revenue
N/A
Gross Margin
0.05%
Dividend Yield
N/A
EPS
$0.09
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Organigram Global Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OGI-9.03%-91.27%-38.59%-84%
S&P+14.39%+76.41%+12.02%+247%

Organigram Global Company Info

Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.

News & Analysis

The Fool has written over 300 articles on Organigram Global.

Financial Health

General

Q4 2025YOY Change
Revenue$45.57M49.1%
Gross Profit$3.15M55144.9%
Gross Margin6.91%6.9%
Market Cap$226.81M11.7%
Market Cap / Employee$199.13K0.0%
Employees1.1K26.8%
Net Income$14.32M187.2%
EBITDA-$10,863.06K6.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$45.35M-5.0%
Accounts Receivable$35.80M27.0%
Inventory96.833.9%

Liabilities

Q4 2025YOY Change
Long Term Debt$5.48M-7.2%
Short Term Debt$690.86K-31.7%

Ratios

Q4 2025YOY Change
Return On Assets3.28%17.0%
Return On Invested Capital-26.96%5.1%

Cash Flow

Q4 2025YOY Change
Free Cash Flow-$12,818.09K-265.7%
Operating Free Cash Flow-$11,309.15K-382.9%

Valuation

MetricQ1 2025Q2 2025Q4 2025YoY Change
Price to Earnings15.0294.9617.55-
Price to Book0.570.670.960.9016.65%
Price to Sales0.981.131.471.15-23.33%
Price to Tangible Book Value0.760.911.311.2759.80%
Price to Free Cash Flow TTM101.02-
Enterprise Value to EBITDA-7.84-11.11-12.97-17.5645.96%
Free Cash Flow Yield1.0%-
Return on Equity4.8%1.9%-7.9%4.8%-126.12%
Total Debt$6.63M$6.70M$6.29M$6.17M-10.77%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.